A carboplatin-based regimen for the trea
β
Eric J. Small; Linda J. Fippin; Mary Lou Ernest; Peter R. Carroll
π
Article
π
1996
π
John Wiley and Sons
π
English
β 622 KB
## EIACKGROUND. Many patients with advanced transitional cell carcinoma are unable to receive cisplatin-based therapy. The efficacy and toxicity of a carboplatin-based regimen in the treatment of patients with advanced transitional cell carcinoma was therefore evaluated. ## METHODS. Twenty-thre